Results 201 to 210 of about 53,957 (281)
Perioperative Outcomes of Nephrectomy for Autosomal Dominant Polycystic Kidney Disease. [PDF]
Bacchus MW +4 more
europepmc +1 more source
Abstract Autosomal polycystic kidney disease (ADPKD) is the most common form of inherited kidney disease. The international guideline developer, Kidney Disease: Improving Global Outcomes (KDIGO), published a 2025 clinical practice guideline reflecting advances in genetic testing and the first disease‐modifying agent, tolvaptan.
Mia E. Abdy +26 more
wiley +1 more source
Cervical Artery Dissection in Autosomal Dominant Polycystic Kidney Disease. [PDF]
Liu A +4 more
europepmc +1 more source
ABSTRACT Aim To develop an in‐depth understanding of peoples' perceptions and experiences of decision‐making and reasons why they declined the opportunity of a kidney transplant. Design The Theory of Planned Behaviour informed the qualitative interpretative phenomenological analysis. Methods Semi‐structured interviews were conducted between August 2022
Emma Jones +3 more
wiley +1 more source
Discussion on Polycystic Disease of the Kidneys [PDF]
openaire +5 more sources
Systemic inflammatory biomarkers linked to <i>PKD1</i> mutation and renal morphometrics in cats with polycystic kidney disease. [PDF]
Jaturanratsamee K +4 more
europepmc +1 more source
Update of the risk assessment on dioxins and dioxin‐like PCBs in feed and food
Abstract The European Commission asked EFSA to update its 2018 risk assessment on polychlorinated dibenzo‐p‐dioxins and dibenzofurans (PCDD/Fs) and dioxin‐like polychlorinated biphenyls (DL‐PCBs) in feed and food, based on the 2022 WHO Toxic Equivalency Factors (WHO2022‐TEFs).
EFSA Panel on Contaminants in the Food Chain (CONTAM Panel) +27 more
wiley +1 more source
The Relationship of Osmolality and Kidney Outcomes in Patients with Autosomal Dominant Polycystic Kidney Disease. [PDF]
Fung WW +24 more
europepmc +1 more source

